Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Compare mRNA/LNP CDMOs in Europe
Compare mRNA/LNP CDMOs in Germany
Compare Oligo/ASO CDMOs in Europe
Compare Oligo/ASO CDMOs in Germany
Compare Biologics CDMOs in Europe
Compare Biologics CDMOs in Germany
Program data pending ClinicalTrials.gov matching
· Last scored 2026-11-02
83.1
Signal Score
✓ FDA Inspections (5)
○ Clinical Trials
○ SEC Filings
✓ Press (1)
✓ EMA GMP (17)
○ MHRA GMP
✓ HC GMP (31)
Quick Facts: Corden Pharma
- Signal Score
- 83.1/100 (as of 2026-11-02)
- Quality Compliance
- 99.3/100 — Clean EMA record: 17 active GMP certificates (no deductions)
- Headquarters
- Plankstadt, DE · Caponago, IT · Boulder, CO
- Modalities
- mRNA, Oligonucleotide, Biologics
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Corden Pharma
Manufactured lipids for BioNTech COVID vaccine.
Signal Score & Pillar Breakdown
Quality Compliance
99.3
Clean EMA record: 17 active GMP certificates (no deductions)
Sources: FDA Data Dashboard, EMA EudraGMDP
Clean EMA record: 17 active GMP certificates (no deductions)
FDA Inspections5 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2025-11-14)
EMA GMP Certificates17 on record
Most Recent HC OutcomeCompliant · 2025-11-10
HC Attribution31 company-level
Source: Health Canada Drug and Health Product Inspections Database. Ratings shown in Health Canada's own vocabulary; not equivalent to FDA classifications. Company-level records are attributed by the regulator's published establishment name, not by a verified site identifier. Contains information licensed under the Open Government Licence – Canada.
Clean EMA record: 17 active GMP certificates (no deductions)
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesmRNA, Oligonucleotide, Biologics
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability
68.0
Parent company: ICIG
Financial assessment: 68.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: ICIG
Financial assessment: 68.0/100
Capacity
70.0
Multi-site operations (6 manufacturing sites)
Sites: Plankstadt, Germany, Caponago, Italy, Boulder, CO, Chenôve, France, Amadora, Portugal, Frankfurt am Main, Germany
Source: company profiles (manufacturing sites, modality breadth)
6 manufacturing sites
Press Signals1 articles (not scored)
Multi-site operations (6 manufacturing sites)
Corden Pharma FDA Inspection History
2025-11
2025-10
2025-03
2022-12
2022-09
NAI
VAI
OAI
| Date | Site | Type | 483 citations posted | Classification |
|---|---|---|---|---|
| 2025-11-14 |
Corden Pharma Colorado, Inc.
Boulder, Colorado
Facility-linked
|
Drug Quality Assurance | Not posted | No Action Indicated (NAI) |
| 2025-10-15 |
Corden Pharma GmbH
Plankstadt
Facility-linked
|
Drug Quality Assurance | Not posted | Voluntary Action Indicated (VAI) |
| 2025-03-28 |
Corden Pharma S.p.A.
Caponago
Facility-linked
|
Drug Quality Assurance | Not posted | Voluntary Action Indicated (VAI) |
| 2022-12-02 |
Corden Pharma S.p.A.
Caponago
Facility-linked
|
Drug Quality Assurance | Not posted | Voluntary Action Indicated (VAI) |
| 2022-09-14 |
Corden Pharma GmbH
Plankstadt
Facility-linked
|
Drug Quality Assurance | Not posted | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Nov 21, 2026
Corden Pharma EMA GMP Compliance 17 certificates
2025-10
2025-10
2025-05
2025-03
2025-03
2025-03
2025-03
2025-03
2025-03
2025-03
2024-10
2024-03
2022-11
2021-11
2019-04
2019-04
2019-04
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| DE_BW_01_GMP_2025_0261 | Corden Pharma GmbH | Germany | 2025-10-15 | COMPLIANT |
| DE_BW_01_GMP_2025_0260 | Corden Pharma GmbH | Germany | 2025-10-15 | COMPLIANT |
| 2025_HPF_FR_090 | Corden Pharma Chenove | France | 2025-05-15 | COMPLIANT |
| IT/80/H/2025 | Corden Pharma S.p.A. | Italy | 2025-03-28 | COMPLIANT |
| IT/121/H/2026 | Corden Pharma S.p.A. | Italy | 2025-03-28 | COMPLIANT |
| IT/148/H/2026 | Corden Pharma S.p.A. | Italy | 2025-03-28 | COMPLIANT |
| F022/S1/MH/001/2026 | Corden Pharma Lisbon S.A. | Portugal | 2025-03-21 | COMPLIANT |
| F022/S2/MH/001/2026 | Corden Pharma Lisbon S.A. | Portugal | 2025-03-21 | COMPLIANT |
| F022/S2/ME/001/2026 | Corden Pharma Lisbon S.A. | Portugal | 2025-03-21 | COMPLIANT |
| F022/S1/ME/001/2026 | Corden Pharma Lisbon S.A. | Portugal | 2025-03-21 | COMPLIANT |
| DE_HE_01_GMP_2026_0198 | Corden Pharma International GmbH | Germany | 2024-10-10 | COMPLIANT |
| NBF/25/2024/V | Corden Pharma S.p.A. | Italy | 2024-03-01 | COMPLIANT |
| IT-API/44/H/2023 | Corden Pharma Latina S.p.A. | Italy | 2022-11-23 | COMPLIANT |
| IT-API/5/H/2022 | Corden Pharma Latina S.p.A. | Italy | 2021-11-16 | COMPLIANT |
| IT-API/23/H/2020 | CORDEN PHARMA LATINA S.P.A. | Italy | 2019-04-05 | COMPLIANT |
| IT-API/39/H/2021 | CORDEN PHARMA LATINA S.P.A. | Italy | 2019-04-05 | COMPLIANT |
| IT-API/47/H/2021 | CORDEN PHARMA LATINA S.P.A. | Italy | 2019-04-05 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Nov 21, 2026
Japan-accredited overseas site (PMDA)
sterile, general (non-sterile) · 4 sites
- Plankstadt, Germany · Corden Pharma GmbH — general (non-sterile) · valid to May 12, 2028
- Caponago, Italy · Corden Pharma S.p.A. — sterile · valid to Jul 30, 2029
- Boulder, United States · Corden Pharma Colorado, Inc. (2 sites) — general (non-sterile) · valid to Sep 30, 2027
PMDA accreditation of a foreign manufacturing site is recognition within Japan's regulatory system, not an inspection outcome. PMDA's list covers only manufacturing sites outside Japan, so a company's plants in Japan are not on it. Source: PMDA, list of accredited/registered foreign manufacturers (as of Oct 16, 2026), Public Data License 1.0 (terms)
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Nov 20, 2026
Company Signals 1 articles
Company announcements, not verified evidence. They do not change any score.
CordenPharma Colorado Partners with BioMed Realty on Peptide Development Lab Expansion - CHEManager
CordenPharma Colorado Partners with BioMed Realty on Peptide Development Lab Expansion CHEManager.
Frequently Asked Questions About Corden Pharma
How many FDA inspections does Corden Pharma have on record?
CDMO Signal tracks 5 FDA inspections for Corden Pharma, sourced from the FDA inspection database. See the full inspection history above.
Has Corden Pharma received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Corden Pharma.
Does Corden Pharma hold EMA or MHRA GMP certificates?
CDMO Signal tracks 17 EMA GMP certificates for Corden Pharma.
What is Corden Pharma's CDMO Signal Score?
Corden Pharma has a Signal Score of 83/100, based on quality, operations, financial stability, and capacity data.
Evaluating Corden Pharma for a manufacturing program?
Use the free AI matchmaker to compare Corden Pharma against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Curia (RNA/Advanced)
Albany, NY · Albuquerque, NM
Signal Score: 79.5
mRNA, Oligonucleotide, Biologics
Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
Signal Score: 90.1
Biologics, mRNA, Small Molecule API, Oral Solid Dose, High-Potency APIs, Sterile Fill-Finish
FUJIFILM Diosynth Biotechnologies
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
Signal Score: 86.7
AAV, mRNA/LNP, Biologics, mRNA, Microbial Fermentation, Recombinant Protein
Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 83.5
Oligonucleotide, Biologics, AAV
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.9
mRNA, Biologics, Cell Therapy
Compare Corden Pharma with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.